Dianne Hilligoss

2.2k total citations
16 papers, 771 citations indexed

About

Dianne Hilligoss is a scholar working on Immunology, Genetics and Infectious Diseases. According to data from OpenAlex, Dianne Hilligoss has authored 16 papers receiving a total of 771 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 5 papers in Genetics and 3 papers in Infectious Diseases. Recurrent topics in Dianne Hilligoss's work include Neutrophil, Myeloperoxidase and Oxidative Mechanisms (10 papers), Immunodeficiency and Autoimmune Disorders (3 papers) and Hematopoietic Stem Cell Transplantation (3 papers). Dianne Hilligoss is often cited by papers focused on Neutrophil, Myeloperoxidase and Oxidative Mechanisms (10 papers), Immunodeficiency and Autoimmune Disorders (3 papers) and Hematopoietic Stem Cell Transplantation (3 papers). Dianne Hilligoss collaborates with scholars based in United States, Netherlands and Cuba. Dianne Hilligoss's co-authors include Harry L. Malech, John I. Gallin, Steven M. Holland, David E. Kleiner, Victoria Anderson, Sandra Anaya‐O’Brien, Beatriz E. Marciano, Sergio D. Rosenzweig, Dirk Darnell and Martha Marquesen and has published in prestigious journals such as Blood, Gastroenterology and Hepatology.

In The Last Decade

Dianne Hilligoss

15 papers receiving 762 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dianne Hilligoss United States 9 618 182 177 139 127 16 771
Alain Fischer France 10 483 0.8× 183 1.0× 110 0.6× 166 1.2× 212 1.7× 15 751
Xiaochuan Wang China 15 527 0.9× 109 0.6× 174 1.0× 137 1.0× 179 1.4× 55 769
Fethi Mellouli Tunisia 16 240 0.4× 124 0.7× 109 0.6× 102 0.7× 70 0.6× 68 643
D Barge United Kingdom 18 510 0.8× 67 0.4× 146 0.8× 171 1.2× 197 1.6× 28 822
Marta Zelazko Argentina 15 390 0.6× 117 0.6× 106 0.6× 198 1.4× 53 0.4× 32 691
Natalia C. Rochael Brazil 8 542 0.9× 63 0.3× 61 0.3× 86 0.6× 240 1.9× 12 734
Mehdi Yeganeh Iran 15 421 0.7× 53 0.3× 187 1.1× 116 0.8× 86 0.7× 30 619
Chen‐Chung Chu Taiwan 18 288 0.5× 79 0.4× 193 1.1× 140 1.0× 134 1.1× 30 685
Torben Ek Sweden 13 478 0.8× 96 0.5× 51 0.3× 146 1.1× 406 3.2× 30 938
B. Suárez Spain 14 360 0.6× 59 0.3× 39 0.2× 194 1.4× 65 0.5× 25 626

Countries citing papers authored by Dianne Hilligoss

Since Specialization
Citations

This map shows the geographic impact of Dianne Hilligoss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dianne Hilligoss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dianne Hilligoss more than expected).

Fields of papers citing papers by Dianne Hilligoss

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dianne Hilligoss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dianne Hilligoss. The network helps show where Dianne Hilligoss may publish in the future.

Co-authorship network of co-authors of Dianne Hilligoss

This figure shows the co-authorship network connecting the top 25 collaborators of Dianne Hilligoss. A scholar is included among the top collaborators of Dianne Hilligoss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dianne Hilligoss. Dianne Hilligoss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Parta, Mark, Dianne Hilligoss, Corin Kelly, et al.. (2020). Failure to Prevent Severe Graft-Versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide in Chronic Granulomatous Disease. Journal of Clinical Immunology. 40(4). 619–624. 11 indexed citations
2.
Wilder, Jennifer, Sharon Adams, Joie Davis, et al.. (2019). Outcomes of Related and Unrelated Donor Searches Among Patients with Primary Immunodeficiency Diseases Referred for Allogeneic Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation. 25(8). 1666–1673. 8 indexed citations
3.
Kang, Elizabeth M., Mark Parta, Dianne Hilligoss, et al.. (2016). Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for High Risk Chronic Granulomatous Disease (CGD) Patients. Biology of Blood and Marrow Transplantation. 22(3). S327–S328. 1 indexed citations
4.
Parta, Mark, Dianne Hilligoss, Corin Kelly, et al.. (2015). Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide in a Patient with Chronic Granulomatous Disease and Active Infection: A First Report. Journal of Clinical Immunology. 35(7). 675–680. 26 indexed citations
5.
Kang, Elizabeth M., Nicola Wright, Kathy Nicholls, et al.. (2015). Allogeneic Transplantation for P40 CGD Is Curative of Inflammatory Disease. Blood. 126(23). 5515–5515.
6.
Kang, Elizabeth M., Corin Kelly, Dianne Hilligoss, et al.. (2011). A Novel Non Myeloablative Regimen for Related and Unrelated Allogeneic Transplantation of High Risk Patients With Chronic Granulomatous Disease (CGD). Biology of Blood and Marrow Transplantation. 17(2). S295–S295. 2 indexed citations
7.
McDermott, David H., Joseph Lopez, Francis Deng, et al.. (2010). AMD3100 is a potent antagonist at CXCR4R334X, a hyperfunctional mutant chemokine receptor and cause of WHIM syndrome. Journal of Cellular and Molecular Medicine. 15(10). 2071–2081. 52 indexed citations
8.
McDermott, David H., Suk See De Ravin, Hyun Sik Jun, et al.. (2010). Severe congenital neutropenia resulting from G6PC3 deficiency with increased neutrophil CXCR4 expression and myelokathexis. Blood. 116(15). 2793–2802. 62 indexed citations
9.
Ravin, Suk See De, Nora Naumann, Edward W. Cowen, et al.. (2008). Chronic granulomatous disease as a risk factor for autoimmune disease. Journal of Allergy and Clinical Immunology. 122(6). 1097–1103. 159 indexed citations
10.
Feld, Jordan J., Nadeem Hussain, Elizabeth C. Wright, et al.. (2008). Hepatic Involvement and Portal Hypertension Predict Mortality in Chronic Granulomatous Disease. Gastroenterology. 134(7). 1917–1926. 54 indexed citations
11.
Kang, Elizabeth M., et al.. (2008). Treatment of infections in patients with X-linked chronic granulomatous disease (CGD) with gene therapy. Blood Cells Molecules and Diseases. 40(2). 270–271. 1 indexed citations
12.
Malech, Harry L., Gilda F. Linton, Narda Whiting‐Theobald, et al.. (2008). Update on gene therapy for Chronic Granulomatous Disease: Current studies and future approaches. Blood Cells Molecules and Diseases. 40(2). 274–275. 2 indexed citations
13.
Hussain, Nadeem, Jordan J. Feld, David E. Kleiner, et al.. (2007). Hepatic abnormalities in patients with chronic granulomatous disease. Hepatology. 45(3). 675–683. 58 indexed citations
14.
Siddiqui, Sophia, Virgil L. Anderson, Dianne Hilligoss, et al.. (2007). Fulminant Mulch Pneumonitis: An Emergency Presentation of Chronic Granulomatous Disease. Clinical Infectious Diseases. 45(6). 673–681. 100 indexed citations
15.
Kang, Elizabeth M., et al.. (2007). Treatment of Infections in Patients with X-Linked Chronic Granulomatous Disease (XCGD) with Gene Therapy.. Blood. 110(11). 504–504. 1 indexed citations
16.
Marciano, Beatriz E., Sergio D. Rosenzweig, David E. Kleiner, et al.. (2004). Gastrointestinal Involvement in Chronic Granulomatous Disease. PEDIATRICS. 114(2). 462–468. 234 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alain Fischer Breakdown of academic impact, for papers by Xiaochuan Wang Breakdown of academic impact, for papers by Fethi Mellouli Breakdown of academic impact, for papers by D Barge Breakdown of academic impact, for papers by Marta Zelazko Breakdown of academic impact, for papers by Natalia C. Rochael Breakdown of academic impact, for papers by Mehdi Yeganeh Breakdown of academic impact, for papers by Chen‐Chung Chu Breakdown of academic impact, for papers by Torben Ek Breakdown of academic impact, for papers by B. Suárez
Rankless by CCL
2026